Company

Dexcom

Type: public
Ticker: DXCM · NASDAQ
Market value: $30B

Dexcom is public, listed as DXCM on NASDAQ, in Healthcare and pharmaceuticals.

What it sells: continuous glucose monitors, Stelo.

In the language of this map it serves 2 solutions — Wearables and continuous health tracking and Chronic-condition pharmaceuticals — which between them relieve 3 human frictions.

Its neighbourhood

Everything this entry connects to directly. Click any point to follow it.

Sells

Wearables and continuous health trackingMidlife
Chronic-condition pharmaceuticalsMidlife

Human frictions it ultimately relieves

Reached through the solutions above, never directly.

The body starts to fail in ways it did not beforeMidlife
Conditions accumulate and specialists multiplyLate career
The body costs more each yearRetirement

Trends favouring it

Preventive, personalised, and consumer-driven medicineCompounding now. Evidence is visible in company results and data.
Food as medicine and personalised nutritionReal but not yet at scale. The effects described are expected rather than observed.